An Expanded Access Program of CNT-01 in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy
Not Applicable
Recruiting
- Conditions
- Idiopathic triglyceride deposit cardiomyovasculopathy
- Registration Number
- JPRN-jRCT2051220160
- Lead Sponsor
- Akita Yasuhiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients who completed the 52 weeks of administration in the CNT-01-811 study.
Patients who voluntarily signed and dated the informed consent form.
Exclusion Criteria
Patients with diabetic ketoacidosis.
Patients allergic to the ingredients of the investigational product.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method